M3
M3 Inc is a Japanese healthcare technology company providing medical web portals, digital marketing solutions, and clinical trial support services for healthcare professionals and pharmaceutical companies. The company operates m3.com, a leading online platform that connects physicians, medical practitioners, and pharmaceutical sales representatives across Japan and international markets. Its core business activities comprise medical portal operation, pharmaceutical e-detailing services, contract research organization services, digital healthcare solutions, and medical career recruitment platforms. Principal revenue is generated from digital promotional service fees paid by pharmaceutical manufacturers, clinical trial contract fees, and medical recruitment commissions. M3 holds a dominant market position in Japanese digital physician networks, expanding its operations across North America, Europe, and Asia. Headquartered in Tokyo, Japan, the company's common stock is publicly listed and traded on the Prime Market of the Tokyo Stock Exchange under the ticker 2413.
9 of the funds FundTelligence covers report a position in M3.
- Legal name
- M3 INC
- Sector
- Health Care
- Country
- Japan
- Funds holding it
- 9
Funds holding M3
- Schroder ISF Healthcare Innovation — Schroders · 0.45 % (full portfolio disclosed, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.04 % (full portfolio disclosed, September 2026)
- SPP Generation 70-tal — Storebrand · 0.01 % (full portfolio disclosed, October 2026)
- Mercer Passive Global Equity Fund — Mercer · 0.01 % (full portfolio disclosed, December 2025)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.0 % (full portfolio disclosed, September 2026)
- SPP Generation 50-tal — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
- SPP Generation 80-tal — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
- SPP Generation 40-tal — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 9 funds holding it.